Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT2 | O15382 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.38 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3770189 | 0.84 | L3MBTL1 (0.49) | SLC6A2SLC6A4SLC6A3ALDH1A1MAPKAPK2 | |
| SCHEMBL85663 | 0.82 | SLC6A2 (0.50) | SLC6A2SLC6A4SLC6A3ALDH1A1MAPKAPK2 | |
| SCHEMBL1584076 | 0.80 | SLC6A2 (0.49) | SLC6A2SLC6A4SLC6A3ALDH1A1MAPKAPK2 | |
| Hydrochloric Acid SCHEMBL1583739 | 0.79 | SLC6A2 (0.50) | SLC6A2SLC6A4SLC6A3ALDH1A1MAPKAPK2 | |
| SCHEMBL25845878 | 0.78 | BCAT2 (0.59) | BCAT2ALDH1A1HPGDTSHRCHRNA7 | |
| SCHEMBL4396319 | 0.78 | SLC6A2 (0.50) | SLC6A2SLC6A4SLC6A3ALDH1A1MAPKAPK2 | |
| SCHEMBL3656969 | 0.78 | SLC6A2 (0.50) | SLC6A2SLC6A4SLC6A3ALDH1A1MAPKAPK2 | |
| SCHEMBL25240100 | 0.77 | ALDH1A1 (0.51) | ALDH1A1HSP90AA1HPGDTSHRHSD17B10 | |
| SCHEMBL30949227 | 0.77 | SLC6A2 (0.38) | SLC6A2SLC6A4SLC6A3ALDH1A1OPRD1 | |
| Hydrochloric Acid SCHEMBL1583516 | 0.77 | SLC6A2 (0.51) | SLC6A2SLC6A4SLC6A3ALDH1A1MAPKAPK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110819291-B | Polyurethane adhesive for battery flexible package | 中国乐凯集团有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-110819291-A | Polyurethane adhesive for battery flexible package | 中国乐凯集团有限公司 | 2020-02-21 | — | — | CN | claimed |
| CN-109421221-A | A kind of drainpipe injection mold for building | 李才英 | 2019-03-05 | — | — | CN | claimed |
| CN-108864974-A | ANTISTATIC SURFACE PROTECTIVE FILM | 藤森工业株式会社 | 2018-11-23 | — | — | CN | claimed |
| CN-107537565-A | Cross linked amphoteric polymeric supported precious metal catalyst and preparation and alcohol method for oxidation | 中国科学院大连化学物理研究所 | 2018-01-05 | — | — | CN | claimed |
| CN-206374120-U | A kind of drainpipe injection mold for building | 浙江吉天建设有限公司 | 2017-08-04 | — | — | CN | claimed |
| EP-1636216-B1 | BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2010-07-21 | — | — | EP | claimed |
| US-7741341-B2 | Benzimidazole-derivatives as factor Xa inhibitors | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2010-06-22 | — | — | US | claimed |
| JP-2006528213-A | — | — | 2006-12-14 | — | — | JP | claimed |
| EP-1636216-A1 | BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS | Sanofi-Aventis Deutschland GmbH (DE) | 2006-03-22 | — | — | EP | claimed |
| US-20050009829-A1 | Benzimidazole-derivatives as factor Xa inhibitors | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2005-01-13 | — | — | US | claimed |
| WO-2004101553-A1 | BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2004-11-25 | — | — | WO | claimed |
| CN-1017440-B | Flame-retardant resin composition | IDEMITSU KOSAN CO (JP) | 1992-07-15 | — | — | CN | claimed |
| CN-117683500-A | Lithium battery aluminum plastic film outer layer interlayer adhesive and preparation method thereof | 沈阳化工研究院有限公司 | 2024-03-12 | — | — | CN | disclosed |
| US-20230265054-A1 | PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING | GENENTECH, INC. (US) | 2023-08-24 | — | — | US | disclosed |
| CN-115850269-A | Tetrahydro-beta-carboline compound and preparation method and application thereof | 南京工业大学 | 2023-03-28 | — | — | CN | disclosed |
| EP-0527574-A1 | Image forming apparatus | KONICA CORPORATION (JP) | 1993-02-17 | — | — | EP | disclosed |
| US-4612356-A | Homo- and co- (addition) polymers of di-perfluoroalkyl carbamyl group containing (meth) acrylate monomers | CIBA-GEIGY CORPORATION (US) | 1986-09-16 | — | — | US | disclosed |
| US-4584143-A | USED IN FINISHES AND POLYMERS | CIBA GEIGY CORPORATION (US) | 1986-04-22 | — | — | US | disclosed |
| US-4540805-A | HYDROPHOBIC AND OLEOPHOBIC FINISHES | CIBA-GEIGY CORPORATION (US) | 1985-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265054-A1 | PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING | SHH, GLI1, SMO | BCAT2 3816/4885SLC6A2 4842/4885SLC6A4 4548/4885 |
| US-20050009829-A1 | Benzimidazole-derivatives as factor Xa inhibitors | F12, F11, F5 | BCAT2 397/4885SLC6A2 4650/4885SLC6A4 4617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.